Choong Ang Vaccine Laboratory Co. Ltd (072020) — Cash Flow-to-Debt Ratio
Choong Ang Vaccine Laboratory Co. Ltd (072020) has a Cash Flow-to-Debt Ratio of 0.10x as of December 2025, meaning its operating cash flow of ₩1.82 Billion could theoretically repay 0% of its total liabilities (₩17.45 Billion) in one year. See 072020 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Choong Ang Vaccine Laboratory Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Choong Ang Vaccine Laboratory Co. Ltd across 12 annual periods. Also explore net asset momentum of Choong Ang Vaccine Laboratory Co. Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for Choong Ang Vaccine Laboratory Co. Ltd. For market capitalisation and broader financial context, see Choong Ang Vaccine Laboratory Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | ₩7.87 Billion | ₩17.45 Billion | ▼ -34.7% |
| 2024 | 0.69x | ₩13.40 Billion | ₩19.41 Billion | ▲ +7.5% |
| 2023 | 0.64x | ₩12.71 Billion | ₩19.79 Billion | ▲ +77.2% |
| 2022 | 0.36x | ₩7.09 Billion | ₩19.55 Billion | ▼ -37.2% |
| 2021 | 0.58x | ₩11.53 Billion | ₩19.98 Billion | ▲ +20.9% |
| 2020 | 0.48x | ₩8.32 Billion | ₩17.43 Billion | ▼ -41.4% |
| 2019 | 0.81x | ₩8.30 Billion | ₩10.20 Billion | ▲ +67.3% |
| 2018 | 0.49x | ₩5.71 Billion | ₩11.74 Billion | ▲ +9.0% |
| 2017 | 0.45x | ₩7.56 Billion | ₩16.95 Billion | ▼ -23.7% |
| 2016 | 0.59x | ₩7.71 Billion | ₩13.18 Billion | ▼ -57.4% |
| 2015 | 1.37x | ₩9.93 Billion | ₩7.22 Billion | ▲ +77.5% |
| 2014 | 0.77x | ₩6.67 Billion | ₩8.61 Billion | — |